|  | Before matching (N = 316) | After matching (N = 152) | ||||
---|---|---|---|---|---|---|---|
Chemotherapy (n = 215) | No chemotherapy (n = 101) | P-value | Chemotherapy (n = 76) | No chemotherapy (n = 76) | P-value | ||
Sex | Male/female | 108/107 | 45/56 | 0.345a | 38/38 | 34/42 | 0.516a |
Age, years | < 20/20–40/40–60/> 60 Mean, SD | 39/101/54/21 34.7, 16.3 | 11/24/39/27 47.2, 19.1 | < 0.001 b | 15/21/26/16 41.3, 18.5 | 8/23/26/19 45.9, 19.2 | 0.797b |
FNCLCC grade | Grade 2/grade 3 | 4/211 | 8/93 | 0.009 | 2/74 | 4/72 | 0.405 |
Depth | Superficial/deep | 20/195 | 25/76 | < 0.001a | 13/63 | 14/62 | 0.882a |
Location | Trunk/head and neck/upper extremity/lower extremity | 71/7/37/100 | 22/0/19/60 | 0.035a | 17/0/19/40 | 8/0/17/41 | 0.927a |
Length of tumor, cm | < 5/5–10/10–15/> 15 Median, IQR | 65/96/46/8 6.8, 3.6 | 52/33/8/8 5.4, 3.9 | < 0.001b | 35/29/8/4 6.1, 3.9 | 36/28/8/4 5.4, 3.5 | 0.999b |
Stage | I/II/III | 4/94/117 | 8/63/30 | 0.07a | 2/45/29 | 1/48/27 | 0.882a |
Subtype | Monophasic/biphasic/unclassified | 102/63/50 | 51/26/24 | 0.799 | 39/17/20 | 38/19/19 | 0.985a |
Surgical Margin | Wide/marginal/intralesional | 185/20/10 | 83/15/3 | 0.286 | 62/12/2 | 64/9/3 | 0.719 |
Adjuvant radiotherapy | Yes/no | 41/174 | 15/86 | 0.360 | 4/72 | 3/73 | 0.699 |